Zydus Lifesciences Gets USFDA Orphan Drug Status for Promising Beta-Thalassemia Treatment Business Zydus Lifesciences wins USFDA Orphan Drug tag for Desidustat in beta-thalassemia treatment.
Missile Attack From Iran Kills Six In Beit Shemesh, Injures 23, Israeli Authorities Confirm International